Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Yoo MG, Kim IH. Intralesional methotrexate for the treatment of keratoacanthoma: retrospective study and review of the korean literature. Ann Dermatol. 2014;26:172–6.
2. Martorell-Calatayud A, Requena C, Nagore E, et al. Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial. Actas Dermosifiliogr. 2011;102:605–15.
3. Costa C, Scalvenzi M, Fabbrocini G, Villani A.The remarkable increase of squamous cell carcinomas: a retrospective single-center study of 14-years study period. G Ital DermatolVenereol. 2018.
https://doi.org/10.23736/S0392-0488.18.06144-8
.
4. Veerula VL, Ezra N, Aouthmany M, Graham TA, Wolverton SE, Somani AK. Multiple keratoacanthomas occurring in surgical margins and de novo treated with intralesional methotrexate. Cutis. 2016;98:E12–E1515.
5. Remling R, Mempel M, Schnopp N, et al. Intralesional methotrexate injection: an effective time and cost saving therapy alternative in keratoacanthomas that are difficult to treat surgically. Hautarzt. 2000;51:612–4.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献